Hale's Medications & Mothers' Milk (TM) 2025-2026

OZEMPIC | WEGOVY | ENTRESTRO | AND MORE!

Hale's Medications & Mothers' Milk is the ultimate resource for safe medication practices during breastfeeding. This meticulously updated edition offers the most current, evidence-based information available, maintaining its reputation as the definitive standard for medication safety in lactation.

Written by world-renowned clinical pharmacologists, the detailed manual helps lactation consultants, pharmacists, and healthcare providers who work with women and children weigh the relative risks associated with commonly used medications, drawing from the latest evidence-based studies. Structured for quick and efficient use, this guide features Dr. Thomas W. Hale's renowned Lactation Risk Categories (LRC), which provide essential insight, listing safe medication alternatives that can be used now or in the future.

The manual is intuitively organized to highlight key points, offer practical tips, and present easy-to-understand diagrams, common abbreviations, and concise information for evaluating infant health. This indispensable resource helps healthcare professionals to ensure the safety and well-being of both mother and infant. Embrace the peace of mind that comes with having reliable, expert-vetted knowledge at your fingertips.

To ensure you always have the most current information, consider our online or mobile app subscription! Visit halesmeds.com to get started today.

New to the 2025-2026 Edition:

• 66 new drugs
• 10 drugs with FDA updates
• 575 updated medications (formerly medications updated with new information)
• 84 existing drugs with updated LRCs

Key Features:

• Delivers current, evidence-based information on 1,300 drugs, diseases, vaccines, and syndromes in alphabetical order
• Provides critical updates on weight loss drugs such as Wegovy and Ozempic, heart failure drugs such as Entresto, medications for anxiety, postpartum depression, and much more
• Incorporates updates to Dr. Hale's world-renowned Lactation Risk Categories (LRC)
• Discusses adult concerns, adult dose, pediatric concerns, infant monitoring, and drug alternatives